Lexicon Pharmaceuticals LXRX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $69.64M+39.8% | $49.8M-29.7% | $70.86M+21.3% | $58.43M+87.2% | $31.21M+0.4% | ||
| $352K+28.5% | $274K-34.9% | $421K-12.7% | $482K-21.6% | $615K-0.2% | ||
| $69.29M+39.9% | $49.53M-29.7% | $70.44M+21.6% | $57.95M+89.4% | $30.6M+0.4% | ||
| 99.5%0.0pp | 99.4%0.0pp | 99.4%+0.2pp | 99.2%+1.1pp | 98%0.0pp | ||
| $58.58M-4.2% | $61.12M-20.1% | $76.49M-8.4% | $83.52M-2.2% | $85.41M+1.1% | ||
| $34.94M-6.4% | $37.32M-38.6% | $60.82M-34.5% | $92.81M-24.3% | $122.65M-14.3% | ||
| $93.87M-4.9% | $98.71M-28.3% | $137.73M-22.1% | $176.81M-15.3% | $208.68M-8.6% | ||
| -$24.23M+50.5% | -$48.91M+26.9% | -$66.87M+43.5% | -$118.37M+33.3% | -$177.46M+10.0% | ||
| -34.8%+63.4pp | -98.2%-3.8pp | -94.4%+108pp | -202.6%+366pp | -568.6%+65.6pp | ||
| $6.84M-17.9% | $8.33M-14.7% | $9.77M-13.5% | $11.3M-10.6% | $12.63M-2.2% | ||
| $6.23M-9.8% | $6.91M-18.3% | $8.46M-18.1% | $10.33M-18.2% | $12.63M+2.7% | ||
| —— | —— | —— | —— | —— | ||
| -$26.09M+48.2% | -$50.34M+26.6% | -$68.58M+43.1% | -$120.62M+32.0% | -$177.3M+11.5% | ||
| -37.5%+63.6pp | -101.1%-4.3pp | -96.8%+110pp | -206.4%+362pp | -568%+76.7pp | ||
| -$0.07+50.0% | -$0.14+26.3% | -$0.19+42.4% | -$0.33+35.3% | -$0.51+20.3% | ||
| -$23.67M+51.0% | -$48.29M+27.1% | -$66.24M+43.8% | -$117.77M+33.4% | -$176.9M+10.0% | ||
| -34%+63.0pp | -97%-3.5pp | -93.5%+108pp | -201.6%+365pp | -566.7%+65.7pp | ||
| -$24.23M+50.5% | -$48.91M+26.9% | -$66.87M+43.5% | -$118.37M+33.3% | -$177.46M+10.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Lexicon Pharmaceuticals's revenue?
- Lexicon Pharmaceuticals (LXRX) generated $69.6M in revenue over the trailing twelve months, up 123.1% year over year.
- Is Lexicon Pharmaceuticals profitable?
- Lexicon Pharmaceuticals is not currently profitable: it reported a net loss of $26.1M over the trailing twelve months, a -37.5% net margin.
- What are Lexicon Pharmaceuticals's profit margins?
- Gross margin is 99.5% and operating margin is -34.8%, with a -37.5% net margin.
- What is Lexicon Pharmaceuticals's earnings per share?
- Lexicon Pharmaceuticals's diluted EPS over the trailing twelve months is $-0.07.
- Where does Lexicon Pharmaceuticals's income statement data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
